Clinical Trials Directory

Trials / Completed

CompletedNCT07346573

Radiotherapy Safety for Liver Malignancies Using Post-Treatment Imaging

A Retrospective Single-Center Study Utilizing AI-Based Radiomics on Pre- and Post-Radiotherapy CT Images to Explore the Safety Dose Threshold in Liver Malignancy Radiation Therapy

Status
Completed
Phase
Study type
Observational
Enrollment
274 (actual)
Sponsor
Cao peiguo · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The goal of this retrospective observational study is to investigate the safety of radiation therapy for liver malignancies by analyzing data from patients who have already completed this treatment . The main questions it aims to answer are: What is the specific radiation dose level that leads to a visible change on CT scans called a Focal Liver Reaction (FLR)? Why do some patients develop these imaging changes while others do not, based on their scan features and clinical information? Researchers will compare patients who developed FLR with those who did not to identify the factors associated with this reaction. This study uses existing medical records and images; therefore, participants will not need to undergo any new interventions or procedures.

Conditions

Interventions

TypeNameDescription
OTHERClinically Delivered Radiation Therapy (e.g., SBRT/IMRT) for Liver CancerThis is a retrospective observational study. The intervention (radiotherapy) was administered as part of standard clinical care prior to the study. Researchers are analyzing the outcomes of this previously delivered intervention.

Timeline

Start date
2019-05-01
Primary completion
2025-03-01
Completion
2025-03-01
First posted
2026-01-16
Last updated
2026-01-16

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07346573. Inclusion in this directory is not an endorsement.